Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Combination therapy with anti-HIV-1 antibodies maintains viral suppressionNature (London), 2018-09, Vol.561 (7724), p.479-484 [Peer Reviewed Journal]COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Sep 27, 2018 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-018-0531-2 ;PMID: 30258136Full text available |
|
2 |
Material Type: Article
|
Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117Nature (London), 2015-06, Vol.522 (7557), p.487-491 [Peer Reviewed Journal]COPYRIGHT 2015 Nature Publishing Group ;COPYRIGHT 2015 Nature Publishing Group ;Copyright Nature Publishing Group Jun 25, 2015 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature14411 ;PMID: 25855300 ;CODEN: NATUASFull text available |
|
3 |
Material Type: Article
|
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spikeNature (London), 2020-08, Vol.584 (7821), p.450-456 [Peer Reviewed Journal]Copyright Nature Publishing Group Aug 20, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2571-7 ;PMID: 32698192Full text available |
|
4 |
Material Type: Article
|
Combination anti-HIV antibodies provide sustained virological suppressionNature (London), 2022-06, Vol.606 (7913), p.375-381 [Peer Reviewed Journal]2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply. ;Copyright Nature Publishing Group Jun 9, 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04797-9 ;PMID: 35650437Full text available |
|
5 |
Material Type: Article
|
Enhanced neonatal Fc receptor function improves protection against primate SHIV infectionNature (London), 2014-10, Vol.514 (7524), p.642-645 [Peer Reviewed Journal]COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group Oct 30, 2014 ;2014 Macmillan Publishers Limited. All rights reserved 2014 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature13612 ;PMID: 25119033 ;CODEN: NATUASFull text available |
|
6 |
Material Type: Article
|
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challengesNature (London), 2016-05, Vol.533 (7601), p.105-109 [Peer Reviewed Journal]COPYRIGHT 2016 Nature Publishing Group ;COPYRIGHT 2016 Nature Publishing Group ;Copyright Nature Publishing Group May 5, 2016 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature17677 ;PMID: 27120156 ;CODEN: NATUASFull text available |
|
7 |
Material Type: Article
|
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2Nature structural & molecular biology, 2020-09, Vol.27 (9), p.846-854 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. corrected publication 2021. ;ISSN: 1545-9993 ;EISSN: 1545-9985 ;DOI: 10.1038/s41594-020-0469-6 ;PMID: 32661423Full text available |
|
8 |
Material Type: Article
|
Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escapeScience, 2021-02, Vol.371 (6530), p.691 [Peer Reviewed Journal]2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1095-9203 ;EISSN: 1095-9203 ;DOI: 10.1126/science.abe6230Digital Resources/Online E-Resources |
|
9 |
Material Type: Article
|
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibodyScience, 2021-02, Vol.371 (6531) [Peer Reviewed Journal]2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abf4830Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Evolution of antibody immunity to SARS-CoV-2Nature (London), 2021-03, Vol.591 (7851), p.639-644 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Mar 25, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03207-w ;PMID: 33461210Full text available |
|
11 |
Material Type: Article
|
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution SerologyCell, 2020-11, Vol.183 (4), p.1024-1042.e21 [Peer Reviewed Journal]2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.09.037 ;PMID: 32991844Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2Science, 2020-06, Vol.368 (6496) [Peer Reviewed Journal]2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abc2241Digital Resources/Online E-Resources |
|
13 |
Material Type: Article
|
Development of a Human Antibody Cocktail that Deploys Multiple Functions to Confer Pan-Ebolavirus ProtectionCell host & microbe, 2019-01, Vol.25 (1), p.39-48.e5 [Peer Reviewed Journal]2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2018.12.004 ;PMID: 30629917Full text available |
|
14 |
Material Type: Article
|
An expanded benchmark for antibody-antigen docking and affinity prediction reveals insights into antibody recognition determinantsStructure (London), 2021-06, Vol.29 (6), p.606-621.e5 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;ISSN: 0969-2126 ;EISSN: 1878-4186 ;DOI: 10.1016/j.str.2021.01.005 ;PMID: 33539768Full text available |
|
15 |
Material Type: Article
|
Introduction of the YTE mutation into the non-immunogenic HIV bnAb PGT121 induces anti-drug antibodies in macaquesPloS one, 2019-02, Vol.14 (2), p.e0212649 [Peer Reviewed Journal]COPYRIGHT 2019 Public Library of Science ;COPYRIGHT 2019 Public Library of Science ;2019 Rosenberg et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Rosenberg et al 2019 Rosenberg et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0212649 ;PMID: 30785963Full text available |
|
16 |
Material Type: Article
|
The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal AntibodiesFrontiers in immunology, 2020-08, Vol.11, p.1951 [Peer Reviewed Journal]Copyright © 2020 Vaisman-Mentesh, Gutierrez-Gonzalez, DeKosky and Wine. ;COPYRIGHT 2020 Frontiers Research Foundation ;Copyright © 2020 Vaisman-Mentesh, Gutierrez-Gonzalez, DeKosky and Wine. 2020 Vaisman-Mentesh, Gutierrez-Gonzalez, DeKosky and Wine ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2020.01951 ;PMID: 33013848Full text available |
|
17 |
Material Type: Article
|
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strainsNature (London), 2021-08, Vol.596 (7870), p.103-108 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Aug 5, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03720-y ;PMID: 34153975Full text available |
|
18 |
Material Type: Article
|
The role of IgG Fc receptors in antibody-dependent enhancementNature reviews. Immunology, 2020-10, Vol.20 (10), p.633-643 [Peer Reviewed Journal]COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-020-00410-0 ;PMID: 32782358Full text available |
|
19 |
Material Type: Article
|
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaquesNature (London), 2019-06, Vol.570 (7762), p.468-473 [Peer Reviewed Journal]COPYRIGHT 2019 Nature Publishing Group ;Copyright Nature Publishing Group Jun 27, 2019 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-019-1250-z ;PMID: 31142836Full text available |
|
20 |
Material Type: Article
|
Tackling COVID-19 with neutralizing monoclonal antibodiesCell, 2021-06, Vol.184 (12), p.3086-3108 [Peer Reviewed Journal]2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.05.005 ;PMID: 34087172Full text available |